# Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants

> **NCT05999916** · NA · COMPLETED · sponsor: **Bottneuro AG** · enrollment: 8 (actual)

## Conditions studied

- Healthy Participants
- Healthy Population

## Interventions

- **DEVICE:** Personalized Miamind Neurostimulator

## Key facts

- **NCT ID:** NCT05999916
- **Lead sponsor:** Bottneuro AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-27
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-03-22
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05999916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05999916, "Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05999916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*